



| Three Months Ended December 31, | ||||||||||||||
| (in millions, except per share data) | 2021 | 2020 | ||||||||||||
| Net sales | $ | 3,480 | $ | 3,848 | ||||||||||
| Cost of sales | 3,307 | 3,507 | ||||||||||||
| Gross profit | 173 | 341 | ||||||||||||
| Selling, general and administrative expenses | 162 | 149 | ||||||||||||
| Restructuring and impairment costs | 4 | 7 | ||||||||||||
| Equity income (loss) | 33 | 97 | ||||||||||||
| Earnings (loss) before interest and income taxes | 40 | 282 | ||||||||||||
| Net financing charges | 50 | 59 | ||||||||||||
| Other pension expense (income) | (1) | (2) | ||||||||||||
| Income (loss) before income taxes | (9) | 225 | ||||||||||||
| Income tax provision (benefit) | 21 | 52 | ||||||||||||
| Net income (loss) | (30) | 173 | ||||||||||||
| Income attributable to noncontrolling interests | 24 | 23 | ||||||||||||
| Net income (loss) attributable to Adient | $ | (54) | $ | 150 | ||||||||||
| Diluted earnings (loss) per share | $ | (0.57) | $ | 1.58 | ||||||||||
| Shares outstanding at period end | 94.8 | 94.0 | ||||||||||||
| Diluted weighted average shares | 94.6 | 94.8 | ||||||||||||
| December 31, | September 30, | |||||||||||||
| (in millions) | 2021 | 2021 | ||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 2,080 | $ | 1,521 | ||||||||||
Accounts receivable - net | 1,597 | 1,426 | ||||||||||||
| Inventories | 942 | 976 | ||||||||||||
| Assets held for sale | — | 49 | ||||||||||||
| Other current assets | 472 | 1,114 | ||||||||||||
| Current assets | 5,091 | 5,086 | ||||||||||||
| Property, plant and equipment - net | 1,558 | 1,607 | ||||||||||||
| Goodwill | 2,209 | 2,212 | ||||||||||||
| Other intangible assets - net | 549 | 555 | ||||||||||||
| Investments in partially-owned affiliates | 367 | 335 | ||||||||||||
| Assets held for sale | 10 | 25 | ||||||||||||
| Other noncurrent assets | 935 | 958 | ||||||||||||
| Total assets | $ | 10,719 | $ | 10,778 | ||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||
| Short-term debt | $ | 174 | $ | 184 | ||||||||||
| Accounts payable and accrued expenses | 2,599 | 2,519 | ||||||||||||
| Liabilities held for sale | — | 16 | ||||||||||||
| Other current liabilities | 969 | 792 | ||||||||||||
| Current liabilities | 3,742 | 3,511 | ||||||||||||
| Long-term debt | 3,482 | 3,512 | ||||||||||||
| Other noncurrent liabilities | 775 | 797 | ||||||||||||
| Redeemable noncontrolling interests | 41 | 240 | ||||||||||||
| Shareholders' equity attributable to Adient | 2,344 | 2,376 | ||||||||||||
| Noncontrolling interests | 335 | 342 | ||||||||||||
| Total liabilities and shareholders' equity | $ | 10,719 | $ | 10,778 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net income (loss) attributable to Adient | $ | (54) | $ | 150 | ||||||||||
| Income attributable to noncontrolling interests | 24 | 23 | ||||||||||||
| Net income (loss) | (30) | 173 | ||||||||||||
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | ||||||||||||||
| Depreciation | 75 | 70 | ||||||||||||
| Amortization of intangibles | 13 | 10 | ||||||||||||
| Pension and postretirement benefit expense (benefit) | 1 | — | ||||||||||||
| Pension and postretirement contributions, net | (5) | (9) | ||||||||||||
| Equity in earnings of partially-owned affiliates, net of dividends received | (32) | (96) | ||||||||||||
| Derivative loss on the 2021 Yanfeng Transaction | 3 | — | ||||||||||||
| Deferred income taxes | (3) | (2) | ||||||||||||
| Non-cash restructuring and impairment charges | 7 | 6 | ||||||||||||
| Equity-based compensation | 10 | 13 | ||||||||||||
| Other | 2 | (3) | ||||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Receivables | (175) | 246 | ||||||||||||
| Inventories | 26 | (6) | ||||||||||||
| Other assets | — | (78) | ||||||||||||
| Restructuring reserves | (24) | (53) | ||||||||||||
| Accounts payable and accrued liabilities | 104 | (84) | ||||||||||||
| Accrued income taxes | 14 | 44 | ||||||||||||
| Cash provided (used) by operating activities | (14) | 231 | ||||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures | (60) | (71) | ||||||||||||
| Sale of property, plant and equipment | 11 | 10 | ||||||||||||
| Settlement of derivatives | (30) | — | ||||||||||||
| Proceeds from business divestitures | 731 | — | ||||||||||||
| Cash provided (used) by investing activities | 652 | (61) | ||||||||||||
| Financing Activities | ||||||||||||||
| Increase (decrease) in short-term debt | (6) | 3 | ||||||||||||
| Repayment of long-term debt | (2) | (18) | ||||||||||||
| Dividends paid to noncontrolling interests | (59) | (52) | ||||||||||||
| Other | (12) | (1) | ||||||||||||
| Cash provided (used) by financing activities | (79) | (68) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | — | 25 | ||||||||||||
| Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale | 559 | 127 | ||||||||||||
| Less: Change in cash classified within current assets held for sale | — | 1 | ||||||||||||
| Increase (decrease) in cash and cash equivalents | $ | 559 | $ | 128 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Net Sales | ||||||||||||||
| Americas | $ | 1,498 | $ | 1,737 | ||||||||||
| EMEA | 1,230 | 1,604 | ||||||||||||
| Asia | 784 | 554 | ||||||||||||
| Eliminations | (32) | (47) | ||||||||||||
| Total net sales | $ | 3,480 | $ | 3,848 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Adjusted EBITDA | ||||||||||||||
| Americas | $ | 9 | 132 | |||||||||||
| EMEA | 43 | 114 | ||||||||||||
| Asia | 114 | 151 | ||||||||||||
Corporate-related costs (1) | (20) | (19) | ||||||||||||
Restructuring and impairment costs (2) | (4) | (7) | ||||||||||||
Purchase accounting amortization (3) | (14) | (11) | ||||||||||||
Restructuring related charges (4) | (1) | (4) | ||||||||||||
| Stock based compensation | (10) | (13) | ||||||||||||
| Depreciation | (75) | (70) | ||||||||||||
Other items (5) | (2) | 9 | ||||||||||||
| Earnings (loss) before interest and income taxes | 40 | 282 | ||||||||||||
| Net financing charges | (50) | (59) | ||||||||||||
| Other pension income (expense) | 1 | 2 | ||||||||||||
| Income (loss) before income taxes | $ | (9) | 225 | |||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions, except per share data) | 2021 | 2020 | ||||||||||||
| Income available to shareholders | ||||||||||||||
| Net income (loss) attributable to Adient | $ | (54) | $ | 150 | ||||||||||
| Weighted average shares outstanding | ||||||||||||||
| Basic weighted average shares outstanding | 94.6 | 94.0 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Stock options, unvested restricted stock and unvested performance share awards | — | 0.8 | ||||||||||||
| Diluted weighted average shares outstanding | 94.6 | 94.8 | ||||||||||||
| • | Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
| • | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. Adjusted EBITDA excluding adjusted equity income, each as defined herein, is also presented. | ||||
| • | Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, expenses associated with becoming an independent company, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
| • | Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
| • | Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
| • | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income. | ||||
| • | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. | ||||
| • | Free cash flow is defined as cash provided by operating activities less capital expenditures. | ||||
| • | Net debt is calculated as gross debt (short-term and long-term) less cash and cash equivalents. | ||||
| • | "Americas footprint actions" and "EMEA footprint actions" refer to miscellaneous closures / roll off of business. | ||||
| • | "EMEA deconsolidation" refers to the sale of a metals business in Turkey effective October 1, 2021 to a nonconsolidated JV in which Adient retains a noncontrolling interest. | ||||
| • | "China strategic transaction" refers to the disposition of the YFAS JV and the consolidation of CQADNT and LFADNT, all of which were effective on September 30, 2021. | ||||
| • | "China footprint actions" refers to divestitures of smaller, non-core businesses (i.e. remaining fabrics business and Futuris entity). | ||||
| Three Months Ended December 31, | ||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||||||||||||||||
| (in millions, except per share data) | GAAP Results | Adj. | Adjusted Results | GAAP Results | Adj. | Adjusted Results | ||||||||||||||||||||||||||||||||
| Net sales | $ | 3,480 | $ | — | $ | 3,480 | $ | 3,848 | $ | — | $ | 3,848 | ||||||||||||||||||||||||||
Cost of sales (6) | 3,307 | (1) | 3,306 | 3,507 | 5 | 3,512 | ||||||||||||||||||||||||||||||||
| Gross profit | 173 | 1 | 174 | 341 | (5) | 336 | ||||||||||||||||||||||||||||||||
Selling, general and administrative expenses (7) | 162 | (15) | 147 | 149 | (14) | 135 | ||||||||||||||||||||||||||||||||
Restructuring and impairment costs (2) | 4 | (4) | — | 7 | (7) | — | ||||||||||||||||||||||||||||||||
Equity income (loss) (8) | 33 | 1 | 34 | 97 | (3) | 94 | ||||||||||||||||||||||||||||||||
| Earnings (loss) before interest and income taxes (EBIT) | 40 | 21 | 61 | 282 | 13 | 295 | ||||||||||||||||||||||||||||||||
| Memo accounts: | ||||||||||||||||||||||||||||||||||||||
| Depreciation | 75 | 70 | ||||||||||||||||||||||||||||||||||||
| Equity based compensation | 10 | 13 | ||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 146 | $ | 378 | ||||||||||||||||||||||||||||||||||
Net financing charges (9) | 50 | (3) | 47 | 59 | 1 | 60 | ||||||||||||||||||||||||||||||||
Other pension expense (income) (12) | (1) | — | (1) | (2) | — | (2) | ||||||||||||||||||||||||||||||||
| Income (loss) before income taxes | (9) | 24 | 15 | 225 | 12 | 237 | ||||||||||||||||||||||||||||||||
Income tax provision (benefit) (10) | 21 | 4 | 25 | 52 | (1) | 51 | ||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Adient | (54) | 18 | (36) | 150 | 12 | 162 | ||||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share | (0.57) | 0.19 | (0.38) | 1.58 | 0.13 | 1.71 | ||||||||||||||||||||||||||||||||
| Diluted weighted average shares | 94.6 | — | 94.6 | 94.8 | — | 94.8 | ||||||||||||||||||||||||||||||||
| Three months ended December 31, 2021 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,498 | $ | 1,230 | $ | 784 | $ | (32) | $ | 3,480 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 9 | $ | 43 | $ | 114 | $ | (20) | $ | 146 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 0.6 | % | 3.5 | % | 14.5 | % | N/A | 4.2 | % | |||||||||||||||||||||||
| Three months ended December 31, 2020 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,737 | $ | 1,604 | $ | 554 | $ | (47) | $ | 3,848 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 132 | $ | 114 | $ | 151 | $ | (19) | $ | 378 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 7.6 | % | 7.1 | % | 27.3 | % | N/A | 9.8 | % | |||||||||||||||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Adjusted EBITDA | $ | 146 | $ | 378 | ||||||||||
| Adjusted Equity Income | 34 | 94 | ||||||||||||
| Adjusted EBITDA Excluding Adjusted Equity Income | $ | 112 | $ | 284 | ||||||||||
| % of Sales | 3.2 | % | 7.4 | % | ||||||||||
| Three Months Ended December 31, | ||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||||||||||||||||
| (in millions, except effective tax rate) | Income (loss) before income taxes | Tax impact | Effective tax rate | Income (loss) before income taxes | Tax impact | Effective tax rate | ||||||||||||||||||||||||||||||||
| As reported | $ | (9) | $ | 21 | nm | $ | 225 | $ | 52 | 23.1% | ||||||||||||||||||||||||||||
| Adjustments | 24 | 4 | 16.7% | 12 | (1) | (8.3)% | ||||||||||||||||||||||||||||||||
| As adjusted | $ | 15 | $ | 25 | nm | $ | 237 | $ | 51 | 21.5% | ||||||||||||||||||||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Net income (loss) attributable to Adient | (54) | 150 | ||||||||||||
Restructuring and impairment costs | 4 | 7 | ||||||||||||
Purchase accounting amortization | 14 | 11 | ||||||||||||
Restructuring related charges | 1 | 4 | ||||||||||||
| Derivative loss on Yanfeng transaction | 3 | — | ||||||||||||
| Interest accretion on deferred consideration | — | (1) | ||||||||||||
Other items (5) | 2 | (9) | ||||||||||||
Impact of adjustments on noncontrolling interests (11) | (2) | (1) | ||||||||||||
Tax impact of above adjustments and other tax items (10) | (4) | 1 | ||||||||||||
| Adjusted net income (loss) attributable to Adient | $ | (36) | $ | 162 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Diluted earnings (loss) per share as reported | $ | (0.57) | $ | 1.58 | ||||||||||
| Restructuring and impairment costs | 0.04 | 0.07 | ||||||||||||
| Purchase accounting amortization | 0.15 | 0.12 | ||||||||||||
| Restructuring related charges | 0.01 | 0.04 | ||||||||||||
| Derivative loss on Yanfeng transaction | 0.03 | — | ||||||||||||
| Interest accretion on deferred consideration | — | (0.01) | ||||||||||||
Other items (5) | 0.02 | (0.09) | ||||||||||||
Impact of adjustments on noncontrolling interests (11) | (0.02) | (0.01) | ||||||||||||
Tax impact of above adjustments and other tax items (10) | (0.04) | 0.01 | ||||||||||||
| Adjusted diluted earnings (loss) per share | $ | (0.38) | $ | 1.71 | ||||||||||
| December 31 | September 30, | |||||||||||||
| (in millions) | 2021 | 2021 | ||||||||||||
| Cash and cash equivalents | $ | 2,080 | $ | 1,521 | ||||||||||
| Total short-term and long-term debt | 3,656 | 3,696 | ||||||||||||
| Net debt | $ | 1,576 | $ | 2,175 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Cash provided by operating activities | $ | (14) | $ | 231 | ||||||||||
| Capital expenditures | (60) | $ | (71) | |||||||||||
| Free cash flow | $ | (74) | $ | 160 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Adjusted EBITDA | $ | 146 | $ | 378 | ||||||||||
| (+/-) Net equity in earnings | (32) | (93) | ||||||||||||
| (-) Restructuring (cash) | (24) | (55) | ||||||||||||
| (+/-) Net customer tooling | 2 | (8) | ||||||||||||
| (+/-) Trade working capital (Net AR/AP + Inventory) | 75 | 250 | ||||||||||||
| (+/-) Accrued compensation | (61) | (19) | ||||||||||||
| (-) Interest paid | (41) | (66) | ||||||||||||
| (+/-) Tax refund/taxes paid | (8) | (12) | ||||||||||||
| (+/-) Non-income related taxes (VAT) | 36 | (67) | ||||||||||||
| (+/-) Commercial settlements | (54) | (9) | ||||||||||||
| (+/-) Other | (53) | (68) | ||||||||||||
| Operating cash flow | (14) | 231 | ||||||||||||
| Capital expenditures | (60) | (71) | ||||||||||||
| Free cash flow | $ | (74) | $ | 160 | ||||||||||
| Net sales | Q1 | Q2 | Q3 | Q4 | FY2021 | |||||||||||||||||||||||||||
| Americas - as reported: | 1,737 | 1,644 | 1,440 | 1,343 | 6,164 | |||||||||||||||||||||||||||
| Americas footprint actions | (20) | — | — | (1) | (21) | |||||||||||||||||||||||||||
| Americas - pro forma | 1,717 | 1,644 | 1,440 | 1,342 | 6,143 | |||||||||||||||||||||||||||
| EMEA - as reported: | 1,604 | 1,636 | 1,328 | 996 | 5,564 | |||||||||||||||||||||||||||
| EMEA JV deconsolidation | (25) | (28) | (11) | (35) | (99) | |||||||||||||||||||||||||||
| EMEA footprint actions | (18) | (7) | (6) | 1 | (30) | |||||||||||||||||||||||||||
| EMEA - pro forma | 1,561 | 1,601 | 1,311 | 962 | 5,435 | |||||||||||||||||||||||||||
| Asia - as reported: | 554 | 588 | 516 | 465 | 2,123 | |||||||||||||||||||||||||||
| China strategic transactions | 234 | 199 | 231 | 227 | 891 | |||||||||||||||||||||||||||
| China footprint actions | (44) | (33) | (31) | (13) | (121) | |||||||||||||||||||||||||||
| Asia - pro forma | 744 | 754 | 716 | 679 | 2,893 | |||||||||||||||||||||||||||
| Elimination/corporate: | (47) | (49) | (42) | (33) | (171) | |||||||||||||||||||||||||||
| Total Adient - as reported | 3,848 | 3,819 | 3,242 | 2,771 | 13,680 | |||||||||||||||||||||||||||
| Total Adient - pro forma | 3,975 | 3,950 | 3,425 | 2,950 | 14,300 | |||||||||||||||||||||||||||
| Adjusted EBITDA | Q1 | Q2 | Q3 | Q4 | FY2021 | |||||||||||||||||||||||||||
| Americas - as reported: | 132 | 64 | 23 | 13 | 232 | |||||||||||||||||||||||||||
| Americas footprint actions | (5) | 1 | — | (1) | (5) | |||||||||||||||||||||||||||
| Americas - pro forma | 127 | 65 | 23 | 12 | 227 | |||||||||||||||||||||||||||
| EMEA - as reported: | 114 | 141 | 22 | — | 277 | |||||||||||||||||||||||||||
| EMEA JV deconsolidation | (4) | (5) | — | (8) | (17) | |||||||||||||||||||||||||||
| EMEA footprint actions | (6) | (2) | (1) | (1) | (10) | |||||||||||||||||||||||||||
| EMEA - pro forma | 104 | 134 | 21 | (9) | 250 | |||||||||||||||||||||||||||
| Asia - as reported: | 151 | 121 | 92 | 122 | 486 | |||||||||||||||||||||||||||
| China strategic transactions | (31) | (2) | 10 | (38) | (61) | |||||||||||||||||||||||||||
| China footprint actions | (7) | (5) | (2) | — | (14) | |||||||||||||||||||||||||||
| Asia - pro forma | 113 | 114 | 100 | 84 | 411 | |||||||||||||||||||||||||||
| Elimination/corporate: | (19) | (23) | (19) | (17) | (78) | |||||||||||||||||||||||||||
| Total Adient - as reported | 378 | 303 | 118 | 118 | 917 | |||||||||||||||||||||||||||
| Total Adient - pro forma | 325 | 290 | 125 | 70 | 810 | |||||||||||||||||||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Restructuring charges | $ | 3 | $ | (1) | ||||||||||
| Held for sale asset adjustments | (7) | (6) | ||||||||||||
| $ | (4) | $ | (7) | |||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Transaction costs | $ | (2) | $ | (4) | ||||||||||
| Brazil indirect tax recoveries | 1 | 8 | ||||||||||||
| Gain on previously held interest at YFAS in an affiliate | — | 5 | ||||||||||||
| Other | (1) | — | ||||||||||||
| $ | (2) | $ | 9 | |||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Restructuring related charges | $ | (1) | $ | (3) | ||||||||||
| Brazil indirect tax recoveries | 1 | 8 | ||||||||||||
| Other | (1) | — | ||||||||||||
| $ | (1) | $ | 5 | |||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Purchase accounting amortization | $ | (13) | $ | (10) | ||||||||||
| Transaction costs | (2) | (4) | ||||||||||||
| $ | (15) | $ | (14) | |||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Gain on previously held interest at YFAS in an affiliate | $ | — | $ | (5) | ||||||||||
| Restructuring related charges | — | 1 | ||||||||||||
| Purchase accounting amortization | 1 | 1 | ||||||||||||
| $ | 1 | $ | (3) | |||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Interest accretion on long-term receivable | $ | — | $ | 1 | ||||||||||
| Derivative loss on Yanfeng transaction | (3) | — | ||||||||||||
| $ | (3) | $ | 1 | |||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Brazil indirect tax recoveries | $ | (3) | $ | 3 | ||||||||||
| Other reconciling items | (1) | (2) | ||||||||||||
| $ | (4) | $ | 1 | |||||||||||